Company Filing History:
Years Active: 2022-2023
Title: The Innovative Contributions of Dandan Liu in Antibody Development
Introduction
Dandan Liu is a prominent inventor based in Jiangsu, China, known for her significant contributions to the field of biotechnology, particularly in the development of antibodies. With two patents to her name, Liu's work is focused on innovative therapeutic solutions that target integrin-associated proteins, paving the way for advancements in medical treatments and diagnostics.
Latest Patents
Dandan Liu's latest inventions include two notable patents centered around Anti-CD47 antibodies. The first, titled "Anti-CD47 antibody and use thereof," details novel antibodies and their fragments that specifically bind to integrin-associated proteins or CD47. This patent encompasses a composition comprising these antibodies or fragments, nucleic acids encoding them, and host cells that house these nucleic acids. Furthermore, this invention explores therapeutic and diagnostic applications for the antibodies.
The second patent, "Anti-CD47 antibodies and uses thereof," similarly focuses on a novel antibody targeting CD47 and its fragments. This patent includes a composition of the antibody or its fragments, as well as nucleic acids and host cells containing the same. Like the first, this invention is directed towards the use of these antibodies in therapy and diagnostics, showcasing Liu's commitment to advancing medical science through her innovative research.
Career Highlights
Dandan Liu is associated with Innovent Biologics (Suzhou) Co., Ltd., a company recognized for its groundbreaking work in biologics. Liu’s expertise in antibody development contributes substantially to the company's mission of delivering innovative treatments for cancer and other diseases. Her dedication to research and development is reflected in her patents, which exemplify her innovative mindset and commitment to improving healthcare outcomes.
Collaborations
Throughout her career, Dandan Liu has collaborated with esteemed colleagues, including Bingliang Chen and Junjian Liu. These partnerships foster an environment of creativity and innovation, allowing for the rapid advancement of groundbreaking antibody treatments. Working alongside talented professionals enhances the potential for developing therapies with significant clinical applications.
Conclusion
Dandan Liu is a trailblazer in the field of antibody research, with her patents on Anti-CD47 antibodies highlighting her innovative spirit and dedication to improving medical treatment options. Her contributions at Innovent Biologics (Suzhou) Co., Ltd. and collaborations with other professionals emphasize the importance of teamwork in driving advancements in biotechnology. Through her work, Liu is making lasting impacts on the healthcare industry and paving the way for future innovations.